Non-invasive assessment of hepatic fibrosis by tissue strain imaging in chronic hepatitis C patients

Naoki Hotta

Department of Hepatology, Masuko Memorial Hospital, Nagoya, Japan.

DOI: 10.4236/jbise.2013.68A2003                

Abstract

The development of fibrosis in hepatitis C patients is associated with increased rates of liver cancer. Assessing hepatic fibrosis during interferon treatment for chronic hepatitis C is thus an important factor in treatment planning. Complications such as bleeding may occur in association with liver biopsy and there are also some reports of sampling error [1,2]. In recent years, however, a number of studies looking at noninvasive means of assessing hepatic fibrosis have appeared in the literature [3-5]. The present study was conducted to determine whether it would be possible to apply an easily performed technique of myocardial examination to hepatic fibrosis. We have already documented our findings for strain rate imaging used to differentiate the normal condition, chronic hepatitis and cirrhosis of the liver identified by diagnostic imaging and haematology data [6]. In this study, patients identified by liver biopsy were investigated, and a comparative investigation with several fibrosis markers was carried out.

Keywords

Strain Rate Imaging; Chronic Hepatitis C Patirnts

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Dienstag, J.L. (2002) The role of liver biopsy in chronic hepatitis C. Hepatology, 36, S152-S160. doi:10.1002/hep.1840360720
[2]	Guido, M. and Rugge, M. (2004) Liver biopsy sampling in chronic viral hepatitis. Seminars in Liver Disease, 24, 89-97. doi:10.1055/s-2004-823103
[3]	Mireen, F.R., Katrin, W., Susanne, K., et al. (2009) Liver fibrosis in viral hepatitis: Noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology, 252, 595-604. doi:10.1148/radiol.2523081928
[4]	Olivier, R., Meng, Y., Phillips, J.R., et al. (2009) MR elastography of liver. Preliminary Results Radiology, 240, 440-447.
[5]	Laurent, S., Bertrand, F., Jean, M.H., et al. (2003) Transient elastography: A new noninvasive method for assessment of hepatic fibrosis ultrasound. Ultrasound in Medicine & Biology, 29, 1705-1713.
[6]	Hotta, N., Ayada, M., Okumura, A., et al. (2007) Noninvasive assessment of liver disease-measurement of hepatic fibrosis using tissue strain imaging. Clinical Imaging, 31, 87-924. doi:10.1016/j.clinimag.2006.11.003
[7]	Ichida, F., Tsuji, T., Omata, M. et al. (1996) New Inuyama classification: New criteria for histological assessment of chronic hepatitis. International Hepatology Communications, 6, 112-119. doi:10.1016/S0928-4346(96)00325-8
[8]	Goto, K., Mikami, T., Onozuka, H., et al. (2006) Role of left ventricular regional diastolic abnormalities for global diastolic dysfunction in patients with Hypertrophic cardiomyopathy. Journal of the American Society of Echocardiography, 19, 857-864. doi:10.1016/j.echo.2006.02.013
[9]	Goebel, B., Arnold, R., Koletzeki, E., et al. (2007) Exercise tissue Doppler echocardiography with strain rate imaging in healthy young individyals: Feasibility, normal values and reproducibility. The International Journal of Cardiovascular Imaging, 23, 149-155.
[10]	Thomas, L., McKay, T., Byth, K. et al. (2006) Abnormalities of left atrial function after Cardioversion: An atrial strain rate study. Heart, 93, 89-95.
[11]	Urheim, S., et al. (2000) Myocardial strain by Doppler echocardiography: Validation of a new method to quantify regional myocardial function. Circulation, 102, 1158-1164. doi:10.1161/01.CIR.102.10.1158
[12]	Kawagishi, T. (1999) TDI application measurements. Toshiba Medical Review, 68, 21-25.
[13]	Abe, Y. New cardiovascular applications of apliofeatures and usefulness of TDI-Q. Toshiba Medical Review.
[14]	Kawamoto, M., Mizuguchi, T., Katsuramaki, T. et al. (2006) Assessment of liver fibrosis by a non-invasive method of transient elastography and biochemical markers. World Journal of Gastroenterology, 12, 4325-4330.
[15]	Kazemi, F., Kettaneh, A., Nkontchou, G., et al. (2006) Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. Journal of Hepatology, 45, 230-235. doi:10.1016/j.jhep.2006.04.006
[16]	Castera, L., Vergniol, J., Foucher, J., et al. (2005) Prospective comparison of transient elastography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology, 128, 343-350. doi:10.1053/j.gastro.2004.11.018
[17]	Ziol, M., Handra-Luca, A., Kettaneh, A., et al. (2005) Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology, 41, 48-54. doi:10.1002/hep.20506
[18]	Foucher, J., Chanteloup, E., Veergniol, J., et al. (2006) Diagnosis of cirrhosis by transient elastography (FibroScan): A prospective study. Gut, 55, 403-408. doi:10.1136/gut.2005.069153
[19]	Juliett, F., Laurent, C., Pierre, H.B., et al. (2006) Prevalence and factors associated with failure of liver stiffness measurement using Fibroscan in prospective study of 2114 examinations. European Journal of Gastroenterology & Hepatology, 18. 411-412.
[20]	Mireen, F.-R., Mei, F.O., Eva, H., et al. (2007) Real-time elastography for noninvasive assessment of liver fibrosis in chronic viral hepatitis. American Journalism Review, 188, 758-764.
[21]	Toyoda, H., Kumada, T., KAmiyama, N., et al. (2009) B-mode ultrasound with algorithm based on statistical analysis of signals: Evaluation of liver fibrosis in patients with chronic hepatitis C. American Journalism Review, 193, 1-7.
[22]	Laurent, H., Christine, S., Eric, V., et al. (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology, 32, 32-40.
[23]	Colletta, C., Smirne, C., Fabris, C., et al. (2005) Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases. Hepatology, 42, 838-845. doi:10.1002/hep.20814
[24]	Morishima, C., Morgan, T.R., Everhart, J.E., et al. (2006) HCV RNA detection by TMA during the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) trial. Hepatology, 44, 360-367. doi:10.1002/hep.21265
[25]	Fontana, R.J., Sanyal, A.J., Mehta, S., et al. (2006) Portal hypertensive gastropathy in chronic hepatitis C patients with bridging fibrosis and compensated cirrhosis: Results from the HALT-C trial. The American Journal of Gastroenterology, 101, 983-992. doi:10.1111/j.1572-0241.2006.00461.x